Concepedia

Luca Bertamini

LB

Statistics

Publications

12

Citations

423

H-Index

11

Active since

2018

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

University of Bologna

Ospedale Papa Giovanni XXIII

Istituto di Ematologia di Bologna

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Luca Bertamini is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and cell transplantation.

ORCID

Top concepts

Publications per year

2018–2025

12

Publications

12

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

Luca Bertamini, Stefania Oliva, Delia Rota‐Scalabrini et al. · Journal of Clinical Oncology · 2022 · 79 citations · Full text

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

Roberto Mina, Pellegrino Musto, Delia Rota‐Scalabrini et al. · The Lancet Oncology · 2022 · 74 citations · Full text

, , +10

Whole-genome sequencing analysis of semi-supercentenarians

Paolo Garagnani, Julien Marquis, Massimo Delledonne et al. · eLife · 2021 · 69 citations · Full text

, , +23

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

Francesca Gay, Pellegrino Musto, Delia Rota Scalabrini et al. · Blood · 2020 · 44 citations

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial

Elena Zamagni, Stefania Oliva, Francesca Gay et al. · EClinicalMedicine · 2023 · 30 citations · Full text

1–5 of 12